{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:23:28Z","timestamp":1775820208012,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims\u2003<\/jats:title>\n                  <jats:p>Enhanced external counterpulsation (EECP) is a non-invasive treatment (35 one-hour sessions) for patients with refractory angina pectoris (RAP). To avoid interruption of treatment, more knowledge is needed about potential adverse events (AE) of EECP and their appropriate management. To describe occurrence of AE and clinical actions related to EECP treatment in patients with RAP and compare the distribution of AE between responders and non-responders to treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results\u2003<\/jats:title>\n                  <jats:p>A retrospective study was conducted by reviewing medical records of 119 patients with RAP who had undergone one EECP treatment and a 6-min-walk test pre- and post-treatment. Sociodemographic, medical, and clinical data related to EECP were collected from patients\u2019 medical records. An increased walking distance by 10% post-treatment, measured by 6-min-walk test, was considered a responder. The treatment completion rate was high, and the occurrence of AE was low. Adverse events occurred more often in the beginning and gradually decreased towards the end of EECP treatment. The AE were either device related (e.g. muscle pain\/soreness) or non-device related (e.g. bradycardia). Medical (e.g. medication adjustments) and\/or nursing (e.g. extra padding around the calves, wound dressing) actions were used. The AE distribution did not differ between responders (n\u2009=\u200949, 41.2%) and non-responders. Skin lesion\/blister occurred mostly in responders and paraesthesia occurred mostly in non-responders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>Enhanced external counterpulsation appears to be a safe and well-tolerated treatment option in patients with RAP. However, nurses should be attentive and flexible to meet their patients\u2019 needs to prevent AE and early termination of treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjcn\/zvab040","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:44:23Z","timestamp":1617277463000},"page":"152-160","source":"Crossref","is-referenced-by-count":9,"title":["Adverse events and their management during enhanced external counterpulsation treatment in patients with refractory angina pectoris: observations from a routine clinical practice"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-7541","authenticated-orcid":false,"given":"Eline","family":"Wu","sequence":"first","affiliation":[{"name":"Heart and Vascular Theme, Karolinska University Hospital, Karolinska University Hospital, H\u00e4lsov\u00e4gen, SE 141 86 Stockholm, Sweden, SE-141 86 Stockholm, Sweden"},{"name":"School of Health and Welfare, J\u00f6nk\u00f6ping University, J\u00f6nk\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"M\u00e5rtensson","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Health and Welfare, J\u00f6nk\u00f6ping University, J\u00f6nk\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyew","family":"Desta","sequence":"additional","affiliation":[{"name":"Heart and Vascular Theme, Karolinska University Hospital, Karolinska University Hospital, H\u00e4lsov\u00e4gen, SE 141 86 Stockholm, Sweden, SE-141 86 Stockholm, Sweden"},{"name":"Division of Cardiology, Department of Medicine, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Brostr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Nursing, School of Health and Welfare, J\u00f6nk\u00f6ping University, J\u00f6nk\u00f6ping, Sweden"},{"name":"Department of Clinical Neurophysiology, Link\u00f6ping University Hospital, Link\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"2022030307592354000_zvab040-B1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.15420\/ecr.2018:1:2","article-title":"New advances in the management of refractory angina pectoris","volume":"13","author":"Cheng","year":"2018","journal-title":"Eur Cardiol"},{"key":"2022030307592354000_zvab040-B2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022030307592354000_zvab040-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory angina: from pathophysiology to new therapeutic nonpharmacological technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"2022030307592354000_zvab040-B4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"key":"2022030307592354000_zvab040-B5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2022030307592354000_zvab040-B6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.15420\/ecr.2016:26:1","article-title":"Management of refractory angina pectoris","volume":"11","author":"Cheng","year":"2016","journal-title":"Eur Cardiol"},{"key":"2022030307592354000_zvab040-B7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"2022030307592354000_zvab040-B8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccl.2014.04.009","article-title":"Alternative therapy for medically refractory angina: enhanced external counterpulsation and transmyocardial laser revascularization","volume":"32","author":"Soran","year":"2014","journal-title":"Cardiol Clin"},{"key":"2022030307592354000_zvab040-B9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3121\/cmr.2013.1169","article-title":"The role of enhanced external counter pulsation therapy in clinical practice","volume":"11","author":"Sharma","year":"2013","journal-title":"Clin Med Res"},{"key":"2022030307592354000_zvab040-B10","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2022030307592354000_zvab040-B11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/08037051003794375","article-title":"Effects on blood pressure in patients with refractory angina pectoris after enhanced external counterpulsation","volume":"19","author":"Bondesson","year":"2010","journal-title":"Blood Press"},{"key":"2022030307592354000_zvab040-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14017431.2014.994028","article-title":"Enhanced external counterpulsation - effect on angina pectoris, QoL and exercise capacity after 1 year","volume":"49","author":"May","year":"2015","journal-title":"Scand Cardiovasc J"},{"key":"2022030307592354000_zvab040-B13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/JCN.0000000000000638","article-title":"Effectiveness of enhanced external counterpulsation treatment on symptom burden, medication profile, physical capacity, cardiac anxiety, and health-related quality of life in patients with refractory angina pectoris","volume":"35","author":"Wu","year":"2020","journal-title":"J Cardiovasc Nurs"},{"key":"2022030307592354000_zvab040-B14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCN.0000000000000530","article-title":"Experiences of undergoing enhanced external counterpulsation in patients with refractory angina pectoris: a qualitative study","volume":"34","author":"Wu","year":"2019","journal-title":"J Cardiovasc Nurs"},{"key":"2022030307592354000_zvab040-B15","first-page":"15","article-title":"A new mindset for quality and safety: the QSEN competencies redefine nurses' roles in practice","volume":"41","author":"Sherwood","year":"2014","journal-title":"Nephrol Nurs J"},{"key":"2022030307592354000_zvab040-B16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/clc.23516","article-title":"Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris","volume":"44","author":"Wu","year":"2021","journal-title":"Clin Cardiol"},{"key":"2022030307592354000_zvab040-B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2022030307592354000_zvab040-B18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/clc.20766","article-title":"Grading chronic angina pectoris (myocardial ischemia)","volume":"33","author":"Conti","year":"2010","journal-title":"Clin Cardiol"},{"key":"2022030307592354000_zvab040-B19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jclinepi.2008.06.007","article-title":"AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program","volume":"63","author":"Chou","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"2022030307592354000_zvab040-B20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/bmj.2.5402.177","article-title":"Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki","volume":"2","author":"Rickham","year":"1964","journal-title":"Br Med J"},{"key":"2022030307592354000_zvab040-B21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/clc.4960240604","article-title":"The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results","volume":"24","author":"Barsness","year":"2001","journal-title":"Clin Cardiol"},{"key":"2022030307592354000_zvab040-B22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1471-2369-14-193","article-title":"Effect of enhanced external counterpulsation treatment on renal function in cardiac patients","volume":"14","author":"Ruangkanchanasetr","year":"2013","journal-title":"BMC Nephrol"},{"key":"2022030307592354000_zvab040-B23","first-page":"16","article-title":"Expert consensus on the clinical application of enhanced external counterpulsation in elderly people (2019)","volume":"3","author":"Lin","year":"2020","journal-title":"Aging Med (Milton)"},{"key":"2022030307592354000_zvab040-B24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ahj.2005.10.003","article-title":"Impact of body mass index on outcomes of enhanced external counterpulsation therapy","volume":"151","author":"McCullough","year":"2006","journal-title":"Am Heart J"},{"key":"2022030307592354000_zvab040-B25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1358863X09106549","article-title":"The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease","volume":"15","author":"Thakkar","year":"2010","journal-title":"Vasc Med"},{"key":"2022030307592354000_zvab040-B26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ncpcardio0691","article-title":"Primer: practical approach to the selection of patients for and application of EECP","volume":"3","author":"Michaels","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"2022030307592354000_zvab040-B27","author":"Sherwood","year":"2017"},{"key":"2022030307592354000_zvab040-B28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15171\/jcs.2016.028","article-title":"Exploring nurse's communicative role in nurse-patient relations: a qualitative study","volume":"5","author":"Fakhr-Movahedi","year":"2016","journal-title":"J Caring Sci"},{"key":"2022030307592354000_zvab040-B29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12912-015-0067-9","article-title":"Registered nurses' descriptions of caring: a phenomenographic interview study","volume":"14","author":"Andersson","year":"2015","journal-title":"BMC Nurs"},{"key":"2022030307592354000_zvab040-B30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1183\/20734735.018016","article-title":"How to keep good clinical records","volume":"12","author":"Mathioudakis","year":"2016","journal-title":"Breathe (Sheff)"}],"container-title":["European Journal of Cardiovascular Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjcn\/article-pdf\/21\/2\/152\/42672424\/zvab040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjcn\/article-pdf\/21\/2\/152\/42672424\/zvab040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T08:07:00Z","timestamp":1646294820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjcn\/article\/21\/2\/152\/6277381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,18]]},"published-print":{"date-parts":[[2022,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjcn\/zvab040","relation":{},"ISSN":["1474-5151","1873-1953"],"issn-type":[{"value":"1474-5151","type":"print"},{"value":"1873-1953","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,5,18]]}}}